Tag: Alopecia Areata

Sun Pharma’s NDA for Deuruxolitinib garners FDA nod: A potential leap for alopecia areata patients

businessnewstoday- October 8, 2023

Sun Pharmaceutical Industries Ltd announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their investigational drug, ... Read More

Pfizer gets LITFULO FDA approval for severe alopecia areata

businessnewstoday- June 24, 2023

Pfizer has announced that the US Food and Drug Administration (FDA) has granted approval to LITFULO (ritlecitinib) as a once-daily oral treatment for individuals aged ... Read More

Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise

Raghuram Kadari- January 20, 2023

India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More